This article presents a case of successful dabrafenib and trametinib combination therapy in a patient with <i>BRAF</i> <sup>V600E</sup>-mutant non-small-cell lung cancer who had a history of radiation pneumonitis and developed recurrence after conventional chemoradiotherapy. Here, BRAF is linked to radiation pneumonitis.